Anti-IL13(lebrikizumab biosimilar) mAb

Price: 50μg $82.00 ; 100 μg $162.00

SKU: BME100548 Category: Biosimilar reference antibodies

Common Name	DRM 06;DRM-06;DRM06;DRM 6;DRM-6;DRM6;LY 3650150;LY-3650150;LY3650150;MILR1444A;MILR-1444A;MILR 1444;ARG 3637;ARG-3637;ARG3637;RO 5490255;RO-5490255;RO5490255;TNX 650;TNX-650;TXN650
Synonyms	P600;IL-13;NC30
Applications	N/A
Recommended Dilutions	N/A
Formulation & Reconstitution	Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Host Species	N/A
IgG type	IgG4
Reactivity	Human
Target	IL13
Uniprot ID	P35225
Description	Anti-IL13(lebrikizumab biosimilar，IgG4) mAb
Delivery	3-4 weeks
Storage & Shipping	Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
Background	Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Usage	Research use only；All DIMA recombinant antibodies are genuinely generated by DIMA Biotech. They are all under patent application. Any protein sequencing or reverse engineering attempt is prohibited. We are actively scrutinizing all patent application to ensure no IP infringement.
Conjugate	Unconjugated